★★★★★
https://www.hindawi.com/journals/ecam/2022/3125662/
Here is a relevant quote from the study :
' During the third wave of the COVID-19 pandemic, only 30% of initially symptomatic nonhospitalized and nonvaccinated subjects were asymptomatic about 18 days after symptom onset. Anosmia affected 50% of subjects and was the most frequently persisting symptom in 30%. Hesperidin therapy is safe and may help reduce a composite of selected COVID-19 symptoms, including fever, cough, shortness of breath, and anosmia. Further trials with this agent are encouraged. This research has previously been published as a preprint [28]. '
Art
